What is NVIDIA Clara?
Clara offers advanced tools and pre-trained AI models that are facilitating remarkable progress across a variety of industries, including healthcare technologies, medical imaging, pharmaceutical innovation, and genomic exploration. Explore the detailed workflow involved in the creation and application of medical devices through the Holoscan platform. Utilize the Holoscan SDK to design containerized AI applications in partnership with MONAI, thereby improving deployment capabilities in cutting-edge AI devices with the help of NVIDIA IGX developer kits. Additionally, the NVIDIA Holoscan SDK features acceleration libraries specifically designed for the healthcare sector, along with pre-trained AI models and sample applications that cater to computational medical devices. This strategic blend of tools not only promotes innovation and efficiency but also empowers developers to address intricate challenges within the medical landscape. As a result, the framework provided by Clara positions professionals at the forefront of technological advancements in healthcare.
Integrations
Similar Software to NVIDIA Clara
SciSure is a platform for managing laboratory operations end-to-end, built for scientific organizations. It brings together ELN, LIMS, and Health & Safety tools so teams can document experiments, track samples, manage chemical inventory, and maintain compliance workflows that are structured and audit-ready.
By replacing fragmented systems with a single governed platform, SciSure helps organizations improve reproducibility, gain clearer operational visibility, and scale lab operations with less risk.
Learn more
Runpod offers a robust cloud infrastructure designed for effortless deployment and scalability of AI workloads utilizing GPU-powered pods. By providing a diverse selection of NVIDIA GPUs, including options like the A100 and H100, Runpod ensures that machine learning models can be trained and deployed with high performance and minimal latency. The platform prioritizes user-friendliness, enabling users to create pods within seconds and adjust their scale dynamically to align with demand. Additionally, features such as autoscaling, real-time analytics, and serverless scaling contribute to making Runpod an excellent choice for startups, academic institutions, and large enterprises that require a flexible, powerful, and cost-effective environment for AI development and inference. Furthermore, this adaptability allows users to focus on innovation rather than infrastructure management.
Learn more
NVIDIA BioNeMo
BioNeMo is a cloud-based platform designed for drug discovery that harnesses artificial intelligence and employs NVIDIA NeMo Megatron to enable the training and deployment of large biomolecular transformer models at an impressive scale. This service provides users with access to pre-trained large language models (LLMs) and supports multiple file formats pertinent to proteins, DNA, RNA, and chemistry, while also offering data loaders for SMILES to represent molecular structures and FASTA for sequences of amino acids and nucleotides. In addition, users have the flexibility to download the BioNeMo framework for local execution on their own machines. Among the notable models available are ESM-1, which is based on Meta AI’s state-of-the-art ESM-1b, and ProtT5, both fine-tuned transformer models aimed at protein language tasks that assist in generating learned embeddings for predicting protein structures and properties. Furthermore, the platform will incorporate OpenFold, an innovative deep learning model specifically focused on forecasting the 3D structures of new protein sequences, which significantly boosts its capabilities in biomolecular exploration. Overall, this extensive array of tools establishes BioNeMo as an invaluable asset for researchers navigating the complexities of drug discovery in modern science. As such, BioNeMo not only streamlines research processes but also empowers scientists to make significant advancements in the field.
Learn more
Recursion
Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.
Learn more
Screenshots and Video
Company Facts
Company Name:
NVIDIA
Date Founded:
1993
Company Location:
United States
Company Website:
developer.nvidia.com/industries/healthcare
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English